Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Austria

Research and Innovation Action · Running

ID-DarkMatter-NCD Unraveling the dark matter of infectious diseases, environmental and genetic factors tipping the balance towards NCDs

Coordinator
Medizinische Universitaet Wien, Austria
Runs
1 January 2024 to 31 December 2028
Status
Running
EU funding
€7.2m
Total cost
€7.2m
Partners
13 organisations in 8 countries
Type
Research and Innovation Action
Grant agreement
101136582

What the project is doing

In the project's own words, from its summary on CORDIS.

While it is known that post-COVID-19-condition (PCC) is caused by SARS-CoV-2 infection, for most other immune-related noncommunicable diseases (IR-NCDs), no such infectious disease (ID) triggers have been identified (yet). Many IDs exist that could potentially cause IR-NCDs, however these microbes have large genomes encoding many antigens possibly associated with IR-NCDs. Given that it is challenging to measure all these 100,000s of structures in parallel, they represent the dark matter of ID-immune interactions.

Furthermore, exposure to an ID alone typically does not trigger development of an IR-NCD: For example only a subset of patients infected with SARS-CoV-2 develop PCC. So, genetic- and environmental aspects also affect the onset of IR-NCDs, but the exact factors are unknown for most IR-NCDs. Here, we aim to 1.) identify IDs triggering IR-NCDs by screening for antibody responses against 600,000 ID antigens, and 2.) to disentangle environmental and genetic factors affecting the transition from IDs to IR-NCDs.

We will combine novel multi-omics approaches and technologies for personalized genotyping of HLA and adaptive immune receptor genes to deeply profile 6,000 patients of six IR-NCDs (PCC, multiple sclerosis, ME/CFS, rheumatoid arthritis, lupus, IBD) to identify novel biomarkers and disease mechanisms. This project will represent the largest and most deeply profiled systematic study of multiple IR-NCDs with layered datasets allowing for comparative analyses yielding insights into shared mechanisms and potential differences in the role of IDs between IR-NCDs.

Building on associations identified from population scale and clinical cohorts, we will demonstrate causality in gnotobiotic mouse models, and leverage machine learning (ML) algorithms to predict disease progression and response to treatment. The combination of novel assays with ML represents a broadly applicable pipeline that can be used for studying the interplay of any other IDs/ IR-NCDs.

Topics

Who is involved

OrganisationCityCountryRole
Medizinische Universitaet WienWienAustriaCoordinator
Eutema Research Services GmbHWienAustriaParticipant
Universitat BaselBaselSwitzerlandAssociatedpartner
Christian-Albrechts-Universitaet Zu KielKielGermanyThird party
Universitatsklinikum Schleswig-HolsteinLübeckGermanyParticipant
Fundacio Hospital Universitari Vall D'hebron - Institut De RecercaBarcelonaSpainParticipant
Assistance Publique Hopitaux De ParisParisFranceParticipant
Sorbonne UniversiteParisFranceParticipant
Hun-Ren Szegedi Biologiai KutatokozpontSzegedHungaryParticipant
HUN-REN Szegedi Biologiai KutatokozpontSzegedHungaryParticipant
Academisch Ziekenhuis GroningenGroningenNetherlandsParticipant
Academisch Ziekenhuis LeidenLeidenNetherlandsParticipant
Karolinska InstitutetStockholmSwedenParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI